States seek to expand lawsuit against generic drugmakers

October 31, 2017
States seek to expand lawsuit against generic drugmakers
In this Tuesday, Feb. 5, 2013, file photo, Connecticut Attorney General George Jepsen speaks at the Justice Department in Washington. On Tuesday, Oct. 31, 2017, Jepsen and 45 of his colleagues sought to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies. (AP Photo/Jacquelyn Martin, File)

Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.

Led by Connecticut, the states sought a federal court's permission Tuesday to widen their complaint, which alleges a number of illegal agreements among 18 manufacturers to fix prices and divvy up the market for specific generic drugs including treatments for high blood pressure, arthritis and asthma.

Mylan N.V., one of the drugmakers named in the suit, said it has investigated the allegations thoroughly and "found no evidence of price fixing." Mylan also said it stands by Rajiv Malik, its president since January 2012 who was named in the expanded complaint.

Based outside of Pittsburgh, Mylan makes a range of generic and branded drugs, including the EpiPen emergency allergy injector. Shares of the company slid 6.6 percent to close at $35.71.

The original lawsuit filed last year claimed six drugmakers artificially inflated and manipulated prices for two drugs, an antibiotic and a diabetes drug. At the time, Connecticut Attorney General George Jepsen said "it was just the tip of the iceberg."

Jepsen said Tuesday the alleged collusion is "so pervasive that it essentially eliminated competition from the market" for 15 generic drugs.

Explore further: States seek to expand lawsuit against generic drug-makers

Related Stories

States seek to expand lawsuit against generic drug-makers

October 31, 2017
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drug-makers to include more manufacturers and medications, as well as senior executives at two companies.

Generic drugmakers want antitrust lawsuit dismissed

May 3, 2017
Six generic drugmakers are asking a federal judge in Connecticut to dismiss a 40-state lawsuit accusing them of artificially inflating and manipulating prices to reduce competition for antibiotic and oral diabetes medication.

Connecticut leads 20-state lawsuit over drug pricing

December 15, 2016
Six generic drug-makers artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication, 20 state attorneys general, led by Connecticut, said in a federal lawsuit filed Thursday.

EpiPen maker finalizes settlement for government overcharges

August 17, 2017
EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade—charges brought after rival Sanofi filed a whistleblower ...

Mylan, like other generic drugmakers, feels the pricing pain

August 9, 2017
Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory ...

FDA takes steps to boost generic competition, limit prices

June 27, 2017
The Food and Drug Administration is taking steps to boost the number of generic prescription drugs in an effort to make medicines more affordable and to prevent price gouging.

Recommended for you

Research finds opioids may help chronic pain, a little

December 18, 2018
Use of opioids for patients with chronic, non-cancer pain may help, but not a lot.

Early postpartum opioids linked with persistent usage

December 14, 2018
Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum ...

Early physical therapy can reduce risk, amount of long-term opioid use, study finds

December 14, 2018
Patients who underwent physical therapy soon after being diagnosed with pain in the shoulder, neck, low back or knee were approximately 7 to 16 percent less likely to use opioids in the subsequent months, according to a new ...

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.